Supernus Pharmaceuticals
SUPN
#4533
Rank
โ‚น244.69 B
Marketcap
โ‚น4,207
Share price
1.10%
Change (1 day)
7.11%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: โ‚น244.69 Billion

As of August 2026 Supernus Pharmaceuticals has a market cap of โ‚น244.69 Billion. This makes Supernus Pharmaceuticals the world's 4533th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น244.69 B-7.82%
2025โ‚น265.44 B50.72%
2024โ‚น176.12 B33.81%
2023โ‚น131.62 B-17.51%
2022โ‚น159.56 B38.24%
2021โ‚น115.42 B18.65%
2020โ‚น97.28 B9.48%
2019โ‚น88.85 B-26.88%
2018โ‚น121.52 B-6.83%
2017โ‚น130.43 B53.45%
2016โ‚น85.00 B94.21%
2015โ‚น43.76 B93.61%
2014โ‚น22.60 B21.37%
2013โ‚น18.62 B54.93%
2012โ‚น12.02 B

End of Day market cap according to different sources

On Aug 30th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

โ‚น241.86 Billion
by Nasdaq info icon info icon
โ‚น242.03 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น60.961 T 24,813.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น18.170 T 7,325.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น98.149 T 40,011.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น12.985 T 5,206.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
โ‚น142.74 B-41.66%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
โ‚น2.082 T 751.24%๐Ÿ‡บ๐Ÿ‡ธ USA